Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes acute rejection episodes compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Dill seed versus placebo Pain score · women with moderate or severe primary dysmenorrhoea
2 findings from 1 review
Prurits · patients with chronic kidney disease (CKD) pruritus
1 finding from 1 review
Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants achieving clear or almost clear skin (PASI 90 to 100 or PGA 0 to 1) · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Percentage of participants with adverse effects and severe adverse effects · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of relapses of guttate psoriasis or flares within a period of 6 months after the treatment has finished · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants achieving PASI 75 or PGA 1 to 2 · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in participant satisfaction measures and quality of life assessment measures Overall subjective score on 5 items (appearance of lesions, impairment of daily life, pruritus, burning, and pain) reported through figures · guttate psoriasis
1 finding from 1 review
Intervention not reported
Relapse rate at one year (all studies) · Crohn's disease patients in remission
It is very uncertain whether the intervention changes relapse rate at one year (all studies) (very low certainty).
1 finding from 1 review
Intervention not reported
Relapse rate at one year (sensitivity analysis of Belluzi 1996) · Crohn's disease patients in remission
It is very uncertain whether the intervention changes relapse rate at one year (sensitivity analysis of Belluzi 1996) (very low certainty).
1 finding from 1 review
Intervention not reported
Relapse rate at one year (only EPIC studies) · Crohn's disease patients in remission
The intervention showed no clear difference in relapse rate at one year (only EPIC studies) (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events rate‐Diarrhea · Crohn's disease patients in remission
The intervention probably leads to higher adverse events rate‐Diarrhea (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events rate‐ Upper GI (nausea, vomiting, halitosis, heartburn, dyspepsia, dysgeusia and bloating) · Crohn's disease patients in remission
The intervention probably leads to higher adverse events rate‐ Upper GI (nausea, vomiting, halitosis,… (moderate certainty).
1 finding from 1 review